No Data
No Data
Should We Be Delighted With GSK Plc's (LON:GSK) ROE Of 36%?
UBS Sticks to Its Buy Rating for GlaxoSmithKline (GSK)
GSk Snaps Six Straight Days of Losses
GSK Will Pay Up to $1.5 Billion for CureVac's MRNA Vaccines -- Barrons.com
By Josh Nathan-Kazis The drugmaker GSK plunged into the messenger RNA-based vaccine market Wednesday, announcing it will buy the rights to experimental influenza and Covid-19 mRNA vaccines from the b
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday
Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently. CureVac (CVAC) and GSK (GSK) said they re
Looming Holiday Break Stifles US Equity Futures Pre-Bell
US equity futures were flat before Wednesday's opening bell as traders refrained from making big bets ahead of the Independence Day holiday. Dow Jones Industrial Average futures, the S&P 500 futures a